Role of Pneumonectomy in T1–4N2M0 Non-Small Cell Lung Cancer: A Propensity Score Matching Analysis

BACKGROUND: N2 stage disease constitutes approximately 20%–30% of all non-small cell lung cancer (NSCLC). Concurrently, surgery remains the first-choice treatment for patients with N2 NSCLC if feasible. However, the role of pneumonectomy in N2 NSCLC has rarely been investigated and remains controver...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Suyu, Wang, Qing, Zhu, Wanli, Wei, Juan, Feng, Di, Lv, Xin, Liu, Meiyun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9251381/
https://www.ncbi.nlm.nih.gov/pubmed/35795054
http://dx.doi.org/10.3389/fonc.2022.880515

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9251381/
https://www.ncbi.nlm.nih.gov/pubmed/35795054
http://dx.doi.org/10.3389/fonc.2022.880515

Ejemplares similares